Natural Product-Guided Synthesis of a Spiroacetal Collection Reveals Modulators of Tubulin Cytoskeleton Integrity

The spiro[5.5]ketal moiety forms the underlying structural skeleton of numerous biologically active natural products. Since simplified but characteristic spiroketals derived from the parent natural products retain biological activity, the spiro[5.5]ketal unit can be regarded as a biologically prevalidated framework for the development of natural product-derived compound collections. We report an enantioselective synthesis of spiro[5.5]ketals on solid support. The reaction sequence employs asymmetric boron enolate aldol reactions with the enolate bound to the polymer or in solution as the key enantiodifferentiating step. It proceeds in up to 12 steps on solid support, makes the desired spiroketals available in high overall yields and with high stereoselectivities and is amenable to structural variation of the products. The small spiroketal collection synthesized contains phosphatase inhibitors and compounds that modulate the formation of the tubulin cytoskeleton in human cancer cells without directly targeting microtubules. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2005)

[1]  Gerlach,et al.  A Combinatorial Approach to Polyketide-Type Libraries by Iterative Asymmetric Aldol Reactions Performed on Solid Support We thank the European Commission (TMR Network ERB-FMR XCT 96-0011 and IHP Network HPRN-CT-2000-00014), EPSRC, Pfizer, and Merck for support. , 2000, Angewandte Chemie.

[2]  Anna Vulpetti,et al.  Origins of π-face selectivity in the aldol reactions of chiral E-enol borinates: a computational study using transition state modelling. , 1993 .

[3]  K. Kataoka,et al.  Highly enantioselective Alk-2-enylation of aldehydes through an allyl-transfer reaction. , 2003, Angewandte Chemie.

[4]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[5]  A. Ghose,et al.  A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.

[6]  C. Abell,et al.  The use of trichloroacetimidate-activated resin for ester formation , 1998 .

[7]  I. Paterson,et al.  Studies in polypropionate synthesis: stereoselective synthesis of (−)-denticulatins A and B , 1992 .

[8]  M. Isobe,et al.  Effects of modification of the hydrophobic C-1-C-16 segment of tautomycin on its affinity to type-1 and type-2A protein phosphatases. , 2000, The Biochemical journal.

[9]  White,et al.  Bidirectional asymmetric allylboration. A convenient asymmetric synthesis of C(2)-symmetric 3-methylenepentane-1,5-diols and rapid access to C(2)-symmetric spiroketals , 2000, The Journal of organic chemistry.

[10]  R. Brückner,et al.  Enantioselective synthesis of bis(γ‐butyrolactones). Their oxidative degradation to tetraols as a key step in stereoselective syntheses of 1,3,5,7,9‐pentaol synthons for polyhydroxylated natural products , 1995 .

[11]  G. Roth,et al.  Combinatorial synthesis of natural product-like molecules using a first-generation spiroketal scaffold. , 2002, Journal of combinatorial chemistry.

[12]  J. Furrer,et al.  Multistep synthesis of 2,5-diketopiperazines on different solid supports monitored by high resolution magic angle spinning NMR spectroscopy. , 2000, Journal of combinatorial chemistry.

[13]  Herbert Waldmann,et al.  Asymmetric solid-phase synthesis of 6,6-spiroketals. , 2004, Angewandte Chemie.

[14]  B. E. Evans,et al.  Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. , 1988, Journal of Medicinal Chemistry.

[15]  Ajay,et al.  Recognizing molecules with drug-like properties. , 1999, Current opinion in chemical biology.

[16]  M. Organ,et al.  The synthesis of deoxyfusapyrone. 2. Preparation of the bis-trisubstituted olefin fragment and its attachment to the pyrone moiety. , 2003, The Journal of organic chemistry.

[17]  D. Hazuda,et al.  Structure, stereochemistry, and biological activity of integramycin, a novel hexacyclic natural product produced by Actinoplanes sp. that inhibits HIV-1 integrase. , 2002, Organic letters.

[18]  Françoise Perron,et al.  Chemistry of spiroketals , 1989 .

[19]  I. Paterson,et al.  Total Synthesis of (-)-Ebelactone A and B , 1995 .

[20]  P. Cohen.  The structure and regulation of protein phosphatases. , 1989, Annual review of biochemistry.

[21]  T. Hamaguchi,et al.  Stevastelins, a novel group of immunosuppressants, inhibit dual-specificity protein phosphatases. , 1997, Chemistry & biology.

[22]  S. Ceccarelli,et al.  Stereocontrolled synthesis of polyketide libraries: Boron-mediated aldol reactions with aldehydes on solid support , 1998 .

[23]  M. Crimmins,et al.  Synthesis of the AB spiroketal subunit of spongistatin 1 (altohyrtin A): The Pyrone approach , 1998 .

[24]  H. Waldmann,et al.  Solid-phase synthesis of dysidiolide-derived protein phosphatase inhibitors. , 2002, Journal of the American Chemical Society.

[25]  P. Cohen,et al.  Okadaic acid: a new probe for the study of cellular regulation. , 1990, Trends in biochemical sciences.

[26]  F. Uckun,et al.  Structure-based design of a novel synthetic spiroketal pyran as a pharmacophore for the marine natural product spongistatin 1. , 2000, Bioorganic & medicinal chemistry letters.

[27]  F. Uckun,et al.  Stereocontrolled synthesis of a novel pharmacophore of the tubulin-depolymerizing marine natural product spongistatin , 2000 .

[28]  H. Shima,et al.  The spiroketals containing a benzyloxymethyl moiety at C8 position showed the most potent apoptosis-inducing activity. , 1999, Bioorganic & medicinal chemistry letters.

[29]  H. Waldmann,et al.  Inhibitors of protein tyrosine phosphatases: next-generation drugs? , 2005, Angewandte Chemie.

[30]  D. Schomburg,et al.  AN EFFICIENT SYNTHESIS OF RADICININ ANALOGUES , 1995 .

[31]  Z. Zhang,et al.  Protein tyrosine phosphatases: prospects for therapeutics. , 2001, Current opinion in chemical biology.

[32]  J. Ermolieff,et al.  Protein tyrosine phosphatase 1B inhibitors for diabetes , 2002, Nature Reviews Drug Discovery.

[33]  K. Burgess,et al.  Resin type can have important effects on solid phase asymmetricalkylation reactions , 1997 .

[34]  M. Sodeoka,et al.  Design and synthesis of a dimeric derivative of RK-682 with increased inhibitory activity against VHR, a dual-specificity ERK phosphatase: implications for the molecular mechanism of the inhibition. , 2001, Chemistry & biology.

[35]  H. Nakamoto,et al.  The first and highly enantioselective crotylation of aldehydes via an allyl-transfer reaction from a chiral crotyl-donor. , 2001, Journal of the American Chemical Society.

[36]  J. Goodman,et al.  Enantio- and diastereoselective aldol reactions of achiral ethyl and methyl ketones with aldehydes: the use of enol diisopinocampheylborinates , 1990 .

[37]  A. Murai,et al.  Synthetic studies on ciguatoxin [1]; construction of the spiro acetal part (C46-C55) , 1998 .

[38]  Davidr . Evans,et al.  Stereoselective aldol reactions of chlorotitanium enolates. An efficient method for the assemblage of polypropionate-related synthons , 1991 .

[39]  M. Reggelin,et al.  Towards polyketide libraries — II: Synthesis of chiral aracemic di- and triketides on a solid support , 1998 .

[40]  J. Denu,et al.  Extracellular Regulated Kinases (ERK) 1 and ERK2 Are Authentic Substrates for the Dual-specificity Protein-tyrosine Phosphatase VHR , 1999, The Journal of Biological Chemistry.

[41]  Herbert Waldmann,et al.  From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries. , 2002, Angewandte Chemie.

[42]  C. R. Mcarthur,et al.  Asymmetric Synthesis of 2‐Alkylcyclohexanones on Solid Phases , 1979 .

[43]  E. Hamel,et al.  Synthesis and biological evaluation of a spongistatin AB-spiroketal analogue. , 2002, Bioorganic & Medicinal Chemistry Letters.

[44]  K. Nicolaou,et al.  Synthesis of epothilones A and B in solid and solution phase , 1997, Nature.

[45]  Wei,et al.  Total Synthesis of Sanglifehrin A. , 1999, Angewandte Chemie.

[46]  R. Bakshi,et al.  Major effect of the leaving group in dialkylboron chlorides and triflates in controlling the stereospecific conversion of ketones into either (E)- or (Z)-enol borinates , 1989 .

[47]  A. Myers,et al.  A solid-supported, enantioselective synthesis suitable for the rapid preparation of large numbers of diverse structural analogues of (-)-saframycin A. , 2002, Journal of the American Chemical Society.

[48]  Davidr . Evans,et al.  Double Stereodifferentiating Aldol Reactions. The Documentation of "Partially Matched" Aldol Bond Constructions in the Assemblage of Polypropionate Systems , 1995 .

[49]  K. Nicolaou,et al.  Designed Epothilones: Combinatorial Synthesis, Tubulin Assembly Properties, abd Cytotoxic Action against Taxol-Resistant Tumor Cells† , 1997 .

[50]  Y. Feng,et al.  Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product. , 2001, Journal of the American Chemical Society.